Anthony S. Ferranti

ORCID: 0000-0003-4882-2049

NeuroscienceBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Trofinetide: a pioneering treatment for Rett syndrome”.

Trofinetide: a pioneering treatment for Rett syndrome

Trends in Pharmacological Sciences(2023)10.1016/j.tips.2023.06.008

N/A

0.785DataRank · unranked

24 citations

Anthony S. Ferranti, Colleen M. Niswender, Harrison H. Parent

Acute alcohol and chronic drinking bidirectionally regulate the excitability of prefrontal cortex vasoactive intestinal peptide interneurons

Neuropharmacology(2023)10.1016/j.neuropharm.2023.109638

N/A

0.464DataRank · unranked

21 citations

Carly B. Fabian, Anthony S. Ferranti, Max E. Joffe, Shannon M. Thompson

Prefrontal cortex parvalbumin interneurons exhibit decreased excitability and potentiated synaptic strength after ethanol reward learning

Alcohol(2022)10.1016/j.alcohol.2022.02.003

N/A

0DataRank · unranked

23 citations

Kari A. Johnson, Danny G. Winder, P. Jeffrey Conn, Max E. Joffe, Anthony S. Ferranti

Acute alcohol and chronic drinking bidirectionally regulate the excitability of prefrontal cortex vasoactive intestinal peptide interneurons

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.07.531614

N/A

0DataRank · unranked

2 citations

Anthony S. Ferranti, Max E. Joffe, Shannon M. Thompson

Novel pharmacological targets for GABAergic dysfunction in ADHD

Neuropharmacology(2024)10.1016/j.neuropharm.2024.109897

N/A

0DataRank · unranked

40 citations

Deborah J. Luessen, Colleen M. Niswender, Anthony S. Ferranti